Search research articles
Contact Us
Filters
Showing results (121-130 of 201) with videos related to
Page
of 21
Sort By:
Experimental Eye Research
|
September 12, 2022
Longitudinal characterization of retinal vasculature alterations with optical coherence tomography angiography in a mouse model of tauopathy
Seth Buscho, Erick Palacios, Fan Xia, et al.
Cell Reports
|
July 21, 2021
Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer's disease and frontotemporal dementia
Sagar Gaikwad, Nicha Puangmalai, Alice Bittar, et al.
Cell Death & Disease
|
May 6, 2020
Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer's disease, progressive supranuclear palsy and dementia with Lewy bodies
Nicha Puangmalai, Nemil Bhatt, Mauro Montalbano, et al.
ACS Chemical Neuroscience
|
October 9, 2015
Antibody against Small Aggregated Peptide Specifically Recognizes Toxic Aβ-42 Oligomers in Alzheimer's Disease
Riddhi U Bodani, Urmi Sengupta, Diana L Castillo-Carranza, et al.
Progress in Neurobiology
|
October 12, 2019
Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective
Paul J Derry, Muralidhar L Hegde, George R Jackson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 27, 2015
Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model
Diana L Castillo-Carranza, Marcos J Guerrero-Muñoz, Urmi Sengupta, et al.
Biochemical and Biophysical Research Communications
|
December 25, 2012
Dual role of p53 amyloid formation in cancer; loss of function and gain of toxicity
Cristian A Lasagna-Reeves, Audra L Clos, Diana Castillo-Carranza, et al.
Journal of Alzheimer'S Disease : JAD
|
October 3, 2022
Passive Immunotherapy Targeting Tau Oligomeric Strains Reverses Tauopathy Phenotypes in Aged Human-Tau Mice in a Mouse Model-Specific Manner
Alice Bittar, Rabab Al-Lahham, Nemil Bhatt, et al.
Human Molecular Genetics
|
October 10, 2013
TDP-43 Phosphorylation by casein kinase Iε promotes oligomerization and enhances toxicity in vivo
Darshana K Choksi, Bidisha Roy, Shreyasi Chatterjee, et al.
Annals of Clinical and Translational Neurology
|
April 7, 2017
Tau oligomers in cerebrospinal fluid in Alzheimer's disease
Urmi Sengupta, Erik Portelius, Oskar Hansson, et al.
Page
of 21
Search research articles
Search
Showing results (121-130 of 201) with videos related to
Sort By:
Page
of 21
Experimental Eye Research
|
September 12, 2022
Longitudinal characterization of retinal vasculature alterations with optical coherence tomography angiography in a mouse model of tauopathy
Seth Buscho, Erick Palacios, Fan Xia, et al.
Cell Reports
|
July 21, 2021
Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer's disease and frontotemporal dementia
Sagar Gaikwad, Nicha Puangmalai, Alice Bittar, et al.
Cell Death & Disease
|
May 6, 2020
Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer's disease, progressive supranuclear palsy and dementia with Lewy bodies
Nicha Puangmalai, Nemil Bhatt, Mauro Montalbano, et al.
ACS Chemical Neuroscience
|
October 9, 2015
Antibody against Small Aggregated Peptide Specifically Recognizes Toxic Aβ-42 Oligomers in Alzheimer's Disease
Riddhi U Bodani, Urmi Sengupta, Diana L Castillo-Carranza, et al.
Progress in Neurobiology
|
October 12, 2019
Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective
Paul J Derry, Muralidhar L Hegde, George R Jackson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 27, 2015
Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model
Diana L Castillo-Carranza, Marcos J Guerrero-Muñoz, Urmi Sengupta, et al.
Biochemical and Biophysical Research Communications
|
December 25, 2012
Dual role of p53 amyloid formation in cancer; loss of function and gain of toxicity
Cristian A Lasagna-Reeves, Audra L Clos, Diana Castillo-Carranza, et al.
Journal of Alzheimer'S Disease : JAD
|
October 3, 2022
Passive Immunotherapy Targeting Tau Oligomeric Strains Reverses Tauopathy Phenotypes in Aged Human-Tau Mice in a Mouse Model-Specific Manner
Alice Bittar, Rabab Al-Lahham, Nemil Bhatt, et al.
Human Molecular Genetics
|
October 10, 2013
TDP-43 Phosphorylation by casein kinase Iε promotes oligomerization and enhances toxicity in vivo
Darshana K Choksi, Bidisha Roy, Shreyasi Chatterjee, et al.
Annals of Clinical and Translational Neurology
|
April 7, 2017
Tau oligomers in cerebrospinal fluid in Alzheimer's disease
Urmi Sengupta, Erik Portelius, Oskar Hansson, et al.
Page
of 21